BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36216844)

  • 21. Waldenström's Macroglobulinemia and Cryoglobulinemic Glomerulonephritis: An Unusual Case of Monoclonal Gammopathy of Renal Significance.
    De La Flor JC; Sulca JM; Rodríguez P; Villa D; Sandoval E; Zamora R; Monroy-Condori M; Lipa R; Perez H; Cieza M
    Med Sci (Basel); 2023 Dec; 11(4):. PubMed ID: 38132918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and clinical characteristics and outcome of monoclonal gammopathy of renal significance-related lesions in Latin America.
    Peña C; Schutz NP; Riva E; Valjalo R; Majlis A; López-Vidal H; Lois V; Zamora D; Ochoa P; Shanley C; Gonzalez JT; Fantl D; Correa G; Ramirez J; Mur P; Silva G; Verri V; Rojas C; Escobar K; Glavic G; Méndez GP;
    Nephrology (Carlton); 2020 Jun; 25(6):442-449. PubMed ID: 31825549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
    Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
    Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.
    Said SM; Leung N; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera LH; Sethi S; Zhang P; Nasr SH
    Kidney Int; 2020 Aug; 98(2):498-504. PubMed ID: 32622524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia.
    Gutiérrez-Peredo GB; Filho JCBO; Montaño-Castellón I; Gutiérrez-Peredo AJ; Crusoé EQ; Gusmao-Flores D
    BMC Nephrol; 2022 Aug; 23(1):278. PubMed ID: 35945525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term outcomes in monoclonal gammopathy of renal significance.
    Khera A; Panitsas F; Djebbari F; Kimberger K; Stern S; Quinn J; Rabin N; Kothari J; Alchi B; Haynes R; Winearls C; Roberts I; Ramasamy K
    Br J Haematol; 2019 Sep; 186(5):706-716. PubMed ID: 31141168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
    Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
    Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
    Ciocchini M; Arbelbide J; Musso CG
    Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MGRS - monoclonal gammopathy of renal significance].
    Wieliczko M; Matuszkiewicz-Rowińska J
    Wiad Lek; 2017; 70(6 pt 2):1175-1178. PubMed ID: 29533908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.
    Metcalf BD; Huang J; Kanaan HD; Abukhaled J; Li W; Samarapungavan D; Zarouk S; Zhang PL
    Arch Pathol Lab Med; 2024 Mar; 148(3):e57-e62. PubMed ID: 37787408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
    Gomes-Alves I; Castro-Ferreira I
    Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.
    Yu XJ; Zhou XJ; Wang SX; Zhou FD; Zhao MH
    BMC Nephrol; 2018 Nov; 19(1):322. PubMed ID: 30419839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
    Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a diagnostic nomogram model for predicting monoclonal gammopathy of renal significance.
    Dong Y; Yan G; Zhang Y; Zhou Y; Zhu L; Shang J
    Sci Rep; 2024 Jan; 14(1):990. PubMed ID: 38200026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine.
    Li JP; Du YT; Li S; Rao XR
    Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
    Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
    Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.